Panera Bread is closing its Franklin, Mass., bakery facility next month, resulting in 92 layoffs, as the chain transitions from fresh dough to a centralized parbaking system for its breads and pastries.
The 179-year-old tobacco giant Philip Morris International is closing its Richmond, Virginia office, eliminating 135 positions, as it aggressively restructures around its smoke-free product portfolio, led by the ZYN nicotine pouch brand.
After a relatively subdued 2025, Wall Street's projections for Nvidia's revenue growth remain robust. Analysts are debating whether the chipmaker's current valuation sets the stage for a significant rebound or a period of consolidation.
As the U.S. wine industry grapples with a multi-year slump, iconic tasting rooms are shuttering. The latest casualty is Hall of Fame NFL coach Dick Vermeil's Napa venue, a move reflecting broader shifts in consumer habits and market pressures.
Nvidia is set to make a landmark investment in OpenAI's latest funding round, CEO Jensen Huang confirmed, signaling a deepening alliance between the AI hardware giant and the leading AI research lab. However, reports of internal skepticism at Nvidia introduce uncertainty into the final terms and timing of the deal.
Singapore's Venture Corporation (SGX:V03) has delivered a robust 38% total shareholder return over the past year, buoyed by dividends. However, a closer look reveals declining earnings and revenue, raising questions about the sustainability of its recent market favor and its longer-term trajectory.
The Hong Kong Monetary Authority has detailed its enhanced oversight framework for key retail payment systems, designating networks like Visa, Mastercard, and UnionPay for direct supervision to ensure security and stability in the city's rapidly digitizing economy.
As a significant equity rotation takes hold in early 2026, shifting focus from growth to value, dividend-focused ETFs are emerging as key beneficiaries for investors seeking yield and stability.
Shares of materials and labeling giant Avery Dennison (NYSE: AVY) have shown resilience amid broader market swings, reigniting debate over its intrinsic value. With a significant gap between its current price and analyst targets, investors are weighing its growth in digital identification technologies against persistent sector headwinds.
Glaukos Corporation's iDose TR glaucoma therapy receives a key FDA labeling update, permitting repeat administration. While the news bolsters the company's growth narrative, analysts are divided on whether its current stock price already reflects future potential amid rich valuation metrics.
Goldcom's (GOLD) shares have soared nearly 90% in the past year, leaving investors to grapple with a critical question: has the market already priced in all the good news, or is there still room to run? A deep dive into the valuation metrics reveals a stark contradiction.
With shares of the global sustainability leader up nearly 7x over three years, investors are grappling with a critical question: has the market run too far ahead of fundamentals? A deep dive into valuation metrics suggests caution may be warranted.
Marketing automation firm Klaviyo is deepening its AI capabilities with a new ChatGPT app and a Wunderkind partnership. Yet, despite these strategic moves, its stock performance tells a more cautious story, leaving investors to weigh its growth potential against a significant valuation discount.
Vital Farms (VITL) is drawing renewed investor attention following a series of earnings estimate upgrades and consistent beats. Despite a recent pullback, analysts see significant upside, citing strong brand positioning and operational scale. However, underlying challenges in retail volumes and cash flow present a more complex picture for the pasture-raised egg producer.
Exelixis has filed its next-generation therapy zanzalintinib with U.S. regulators for metastatic colorectal cancer, marking a significant step in its clinical development and potentially enhancing its competitive position in the targeted oncology space.
Driven by a global wave of semiconductor investment, Applied Materials (AMAT) has received a series of analyst upgrades. Mizuho and Deutsche Bank are among those highlighting the company's strategic position to benefit from expansive fab construction in the U.S., Taiwan, and Japan, and its key role in next-generation chip technologies.
Bayer's share price has more than doubled in the past 12 months, yet key valuation models suggest a significant gap remains between its market price and intrinsic value. We examine the metrics behind the rally and the lingering legal and portfolio challenges facing the company.
Investors in Malaysian construction giant WCT Holdings Berhad have enjoyed a 37% return over the past three years, significantly outpacing the broader market, even as the stock faces recent headwinds. Analysis suggests the company's transition to profitability may underpin its longer-term performance.
While Oriental Interest Berhad (KLSE:OIB) posted impressive headline earnings, a deeper look reveals significant share dilution is eroding per-share value and may explain the stock's muted market reaction.
The Malaysian healthcare provider KPJ Healthcare Berhad is demonstrating a strengthened capacity for profitable reinvestment, with its return on capital employed rising to 11% alongside significant capital expansion, pointing to a robust operational model.
